Showing results (2321-2330 of 2,672) with videos related to

Sort By:
Pageof 268
Journal of Natural Products|August 30, 2012
Inhibition of hypoxia inducible factor-2 transcription: isolation of active modulators from marine spongesTawnya C McKee, Daniel Rabe, Heidi R Bokesch, et al.
American Journal of Respiratory Cell and Molecular Biology|October 9, 2012
Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4Joel Michalski, Nobuhiro Kanaji, Xiangde Liu, et al.
Scientific Reports|December 19, 2022
Cardiovascular predictors of mortality and exacerbations in patients with COPDPeter Alter, Tanja Lucke, Henrik Watz, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 19, 2007
Neurocognitive deficits in first-episode schizophrenic patients and their first-degree relativesXiaohong Ma, Qiang Wang, Pak C Sham, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2020
Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cellsAvanish Mishra, Taronish D Dubash, Jon F Edd, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2021
Neuromorphic learning with Mott insulator NiOZhen Zhang, Sandip Mondal, Subhasish Mandal, et al.
BMC Pulmonary Medicine|February 29, 2024
Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONETJennifer A Zader, Rudolf A Jörres, Imke Mayer, et al.
Pediatric Research|May 3, 2024
Meeting the need for effective and standardized neonatology training: a pan-European Master's CurriculumDeanna Santoro, Devin A Zibulsky, Charles C Roehr, et al.
Plos One|October 5, 2011
First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacyPeter A Anton, Terry Saunders, Julie Elliott, et al.
The Lancet. Respiratory Medicine|July 12, 2025
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trialStephanie A Christenson, Nicola A Hanania, Surya P Bhatt, et al.
Pageof 268